Amino-Terminal Pro-B-Type Natriuretic Peptides: Testing in General Populations

James A de Lemos, Per Hildebrandt

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

Screening of general populations with amino-terminal pro-B-type natriuretic peptides (NT-proBNP) holds promise for the detection of significant underlying cardiac structural and functional abnormalities, as well as for the early detection of the propensity to develop future cardiovascular events. In comparative studies to date, NT-proBNP performs at least as well as BNP in the detection of heart disease and prognostication in the general population. In some studies and subgroups, NT-proBNP appears to outperform BNP in population screening. More needs to be learned about noncardiac sources of NT-proBNP variation in "apparently well" populations. Better understanding of these factors may allow optimization of thresholds for screening of apparently well patients and concomitant delineation of patient populations in whom NT-proBNP screening is less appropriate.

Original languageEnglish (US)
Pages (from-to)S16-S20
JournalAmerican Journal of Cardiology
Volume101
Issue number3 SUPPL.
DOIs
StatePublished - Feb 4 2008

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Amino-Terminal Pro-B-Type Natriuretic Peptides: Testing in General Populations'. Together they form a unique fingerprint.

Cite this